SEC Form 4 · accession 0001209191-15-066584
Axovant Sciences Ltd. · AXON
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Adasczik
Officer — Principal Accounting Officer
Period of report
Aug 17, 2015
Accepted (ET)
Aug 18, 2015 · 4:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001636050
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F1 | $14.06 | Aug 17, 2015 | A | 25,000 | A | — | Aug 17, 2025 | Common Shares | 25,000 | 25,000 | D |
Explanation of responses
- F1This option vests over a period of four years, with one quarter of the common shares underlying the option vesting on July 13, 2016 and the remainder vesting in twelve equal quarterly installments thereafter. All common shares underlying such option will become fully vested upon a change in control, as that term is defined in the Issuer's 2015 Equity Incentive Plan.